Hybrigenics' H1 Revenue Down 2 Percent, But Proteomics Services Up 8 Percent - Proteo Monitor

Hybrigenics' H1 receipts Down 2 Percent, simply Proteomics Services Up viii Percent Proteo Monitor Hybrigenics has an R&D system aimed at developing treatments for diseases including endocrine gland cancer and psoriasis , but the bulk of its revenues come from its fee-for-service protein interaction work, which is housed within its Hybrigenics work ... Hybrigenics 2011 first-half results PharmaLive.com (press release) all 3 news articles » Link To Article